PLK2 and Parkinson disease: PLK2 plays a critical role in the phosphorylation of α-synuclein in the central nervous system, a modification that leads to the formation of pathologic aggregates (Lewy bodies) and, consequently, neurotoxicity, as in the case of PD and dementia [89].